Login / Signup

A single-blinded, randomized controlled trial of standard versus higher dose carboplatin-based intravenous chemotherapy for group D and E retinoblastoma.

Pritam Singha RoySafal MuhammedUsha SinghSameeksha GowravajhalaRicha JainAmita TrehanDeepak Bansal
Published in: Pediatric blood & cancer (2023)
Higher dose carboplatin-based intravenous chemotherapy did not result in superior globe or vision salvage in group D or E retinoblastoma.
Keyphrases
  • randomized controlled trial
  • phase ii study
  • locally advanced
  • study protocol
  • high dose
  • phase iii
  • squamous cell carcinoma
  • low dose
  • radiation therapy
  • systematic review
  • clinical trial